Alpine Immune Sciences In... (ALPN)

64.97

0.01 (0.02%)

At close: May 17, 2024, 8:00 PM

Alpine Immune Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-32.18M	-57.76M	-50.33M	-27.94M	-41.85M	-36.49M	-7.78M	-31.46M
Depreciation & Amortization	576K	597K	620K	578K	468K	388K	241K	143K
Stock-Based Compensation	10.63M	9.65M	6.24M	4.14M	3.04M	n/a	838K	3.26M
Other Working Capital	-56.91M	-25.97M	21.07M	53.43M	2.38M	3.15M	-3.42M	871K
Other Non-Cash Items	-8.03M	-475K	274K	261K	140K	1.01M	-6.31M	3.26M
Deferred Income Tax	155K	46K	910K	108K	-344K	-305K	-204K	-3.26M
Change in Working Capital	-50.16M	4.19M	27.04M	52.94M	3.2M	4.67M	-3.35M	1.8M
Operating Cash Flow	-79.01M	-43.75M	-15.25M	30.08M	-35.35M	-28.42M	-16.57M	-26.26M
Capital Expenditures	-487K	-412K	-118K	-802K	-821K	-495K	-586K	-106K
Cash Acquisitions	n/a	112.94M	52.36M	72.02M	-17.58M	n/a	31.13M	n/a
Purchase of Investments	-351.35M	-266.98M	-133.52M	-101.33M	-59.38M	-72.86M	-88.31M	-75.32M
Sales Maturities Of Investments	296.27M	154.05M	81.16M	29.31M	76.97M	105.23M	27.96M	100.73M
Other Investing Acitivies	n/a	-112.94M	-52.36M	-72.02M	17.58M	250K	31.13M	n/a
Investing Cash Flow	-55.56M	-113.35M	-52.48M	-72.82M	16.76M	32.12M	-29.8M	25.3M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	165.12M	102.69M	100.76M	61.38M	24.25M	-991K	42.69M	166K
Financial Cash Flow	165.12M	102.69M	100.76M	61.38M	24.25M	-991K	42.69M	166K
Net Cash Flow	30.56M	-54.53M	32.95M	18.7M	5.67M	2.71M	-3.69M	-788K
Free Cash Flow	-79.5M	-44.17M	-15.37M	29.28M	-36.17M	-28.91M	-17.16M	-26.36M